Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension

NCT00138944 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: placebo
DRUG: eplerenone

Sponsor

University of Erlangen-Nürnberg Medical School